Skip to main content

Table 3 Mesenchymal stromal cells (MSCs) derived molecules (e.g., exosome) in liver failure preclinical models, especially acute liver failure (ALF)

From: Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review

Sources

Model

Intervention

Result (ref)

Umbilical cord

Mice

MSCs-exosome

GPX1 enriched exosomes diminished oxidative stress and also apoptosis [105]

Placenta

Rat

MSCs-exosome

CRP enriched exosome provoked angiogenesis by up-regulation of Wnt signaling axis [149]

Bone marrow

Rat

MSCs-exosome

Stimulation of hepatoprotective impacts by exosome-rich fractionated secretome [150]

Bone marrow

Mice

MSCs-exosome

Suppression of NLRP3 in macrophage and thereby reducing ALF by TNF-É‘ pretreated exosome [107]

Menstrual blood

Mice

MSCs-exosome

Liver function recovery, improved survival rates, and suppressed hepatocellular apoptosis [151]

Umbilical cord

Mice

MSCs-extracellular vesicles

Inhibition of T cell activation in liver tissue following reserve of CD154 expression [147]

Bone marrow

Mice

MSCs-conditioned medium

Promoting hepatocyte proliferation, inhibition of their apoptosis, hindrance of the infiltration of macrophages, improving Th2/Th1 ratio, and enabling hepatic stellate cell (HSC) loss [157]

Bone marrow

Rat

MSCs-conditioned medium

Marked attenuation of panlobular immune cells infiltrates and also hepatocellular apoptosis [210]

ESCs-MSCs

Mice

MSCs-conditioned medium

Supporting hepatocytes growth by VEGF enriched conditioned medium [156]

Bone marrow

Mice

MSCs-exosome

Attenuation of liver inflammation by exosomal miR-20a-5p/intracellular CXCL8 axis [146]

Bone marrow

Rat

MSCs-conditioned medium

Reduced hepatocyte apoptosis [154]

Bone marrow

Rat

MSCs-conditioned medium

Improving the hepatoprotective impacts of the conditioned medium by SMGO potently elicited through inhibition of inflammation and loss of hepatocytes [155]

Amniotic fluid

Mice

MSCs-conditioned medium

Hepatic progenitor-like (HPL)-CM showed superiority over amniotic fluid-MSCs in terms of liver recovery [158]

  1. Silica magnetic graphene oxide (SMGO), NLR family pyrin domain containing 3 (NLRP3), Tumor necrosis factor-É‘ (TNF-É‘), T helper 1/2 (Th1/2), Vascular endothelial growth factor (VEGF), Interleukin 8 (IL-8 or CXCL8), Conditioned medium (CM), Embryonic stem cells (ESCs), Glutathione peroxidase1 (GPX1), C-reactive protein (CRP)